The Nation.



Big Pharma's Payoff

This article appeared in the November 12, 2001 edition of The Nation.

October 25, 2001

Talk about good times for Washington's mercenary culture. Even as officials scrambled to explain why they had not acted more quickly to protect postal workers from anthrax contamination--or to deal with the public's fears regarding the disease--they were showing solicitous concern for Bayer, the maker of the anthrax-fighting antibiotic Cipro.

Faced with the choice of protecting public health or protecting a corporation's intellectual property, Health and Human Services Secretary Tommy Thompson instinctively chose to stand by Bayer, whose Cipro patent doesn't expire until late 2003. Never mind that it could take Bayer twenty months, working nonstop, to meet the government's target of a sixty-day supply for 12 million people, while generic drug companies say they could jointly reach that goal in three months. Initially, Thompson said he had no authority to override Bayer's patent, and it was only after public and Congressional criticism that he used his leverage to force Bayer to reduce its price for Cipro. Of course, if Thompson were to invoke federal law allowing the compulsory licensing of Bayer's Cipro patent to meet the current emergency (paying the company a fair royalty), he would be hard-pressed to keep arguing against similar measures to address the AIDS epidemic in the developing world.

The highly profitable pharmaceutical industry has invested heavily--doubling its campaign contributions between 1996 and 2000 to more than $26 million--to insure that it gets a Congress and Administration friendly to its interests. And it has paid off. In July the House soundly defeated an amendment sponsored by Bernie Sanders that would have allowed US wholesalers and pharmacies to import FDA-approved US-made drugs sold overseas. Given the price differential, such a change could have saved Americans $30 billion or more a year. According to Public Campaign, members who voted to protect Big Pharma from competition received, on average, $9,000 in campaign contributions from that lobby in 1999-2000, compared with $2,800 to members who voted the other way.

Subscriber Login

4 ISSUES FREE

Subscribe Now!

The only way to read this article and the full contents of each week's issue of The Nation online is by subscribing to the magazine. Subscribe now and read this article -- and every article published since for the past five years -- right now.

There's no obligation -- try The Nation for four weeks free.

.
Popular Topics
Most Searched

Issues »

Most Emailed

Issues »

Blogs

» Campaign 08

Obama's New Southern Strategy: Send Biden | Biden's populism--emotional, visceral-- makes the Democratic message feel relevant again. And that will resonate in the south.
Bob Moser

» The Notion

Don't Make Afghanistan the Democrats' War | Memo to Obama/Biden: Drop the mantra that it's "the good war"
Katrina vanden Heuvel

» The Beat

It Looks a Lot Like Unity | Overcoming internal divisions--and a century of tortured political history-Democrats chose Barack Obama as their presidential nominee.
John Nichols

» ActNow!

Leave No Soldier Behind | Can we talk about Iraq now?
Peter Rothberg

» Capitolism

Remember Katrina? | The storm-sized hole at the DNC
Christopher Hayes

» Editor's Cut

Taking On Poverty and Inequality | Unless (and until) we tackle the gap between the very rich and the rest of America--it will be increasingly difficult to confront the major challenges of our time.
Katrina vanden Heuvel

» The Dreyfuss Report

US Massacres Afghan Kids | So much for Obama's "right war."
Robert Dreyfuss

» And Another Thing

In Search of the Elusive PUMAs | Were they McCain supporters all along?
Katha Pollitt